GTX INC Business Operations Contracts & Agreements
40 Contracts & Agreements
- Collaboration Agreements (8 contracts)
- Development Agreements (27)
- Indemnification Agreements (1)
- Sales Agreements (1)
- Services Agreements (1)
- Voting Agreements (2)
- Advisory Services Agreement effective June 14, 2023 between the Registrant and Gunnar F. Kaufmann, Ph.D (Filed With SEC on August 10, 2023)
- Amendment #4 to Collaboration Agreement between Oncternal Therapeutics, Inc. and The University of Texas M.D. Anderson Cancer Center, dated February 19, 2020 (Filed With SEC on August 6, 2020)
- Form of Indemnification Agreement (Filed With SEC on March 16, 2020)
- Amendment #3 to Collaboration Agreement between Oncternal Therapeutics, Inc. and The University of Texas M.D. Anderson Cancer Center, dated September 17, 2018 (Filed With SEC on April 8, 2019)
- Amendment #2 to Collaboration Agreement between Oncternal Therapeutics, Inc. and The University of Texas M.D. Anderson Cancer Center, dated May 1, 2016 (Filed With SEC on April 8, 2019)
- Amendment #1 to Collaboration Agreement between Oncternal Therapeutics, Inc. and The University of Texas M.D. Anderson Cancer Center, dated January 24, 2016 (Filed With SEC on April 8, 2019)
- Collaboration Agreement between Oncternal Therapeutics, Inc. and The University of Texas M.D. Anderson Cancer Center, dated December 15, 2014 (Filed With SEC on April 8, 2019)
- Form of Oncternal Voting Agreement, dated March 6, 2019, by and between GTx, Oncternal and each of the parties named in each agreement therein (Filed With SEC on March 7, 2019)
- Form of GTx Voting Agreement, dated March 6, 2019, by and between Oncternal, GTx and each of the parties named in each agreement therein (Filed With SEC on March 7, 2019)
- At-the-Market Equity Offering Sales Agreement by and between GTx, Inc. and Stifel, Nicolaus & Company, Incorporated, dated February 9, 2018 (Filed With SEC on February 9, 2018)
- the anticipated progress of our research, development and clinical programs, including whether any future clinical trials we conduct will achieve similar results to clinical... (Filed With SEC on March 8, 2011)
- the anticipated progress of our research, development and clinical programs, including whether current and future clinical trials will achieve similar results to clinical trials... (Filed With SEC on March 15, 2010)
- the anticipated progress of our research, development and clinical programs, including whether current and future clinical trials will achieve similar results to clinical trials... (Filed With SEC on March 15, 2010)
- the anticipated progress of our research, development and clinical programs, including whether current and future clinical trials will achieve similar results to clinical trials... (Filed With SEC on March 15, 2010)
- the anticipated progress of our research, development and clinical programs, including whether current and future clinical trials will achieve similar results to clinical trials... (Filed With SEC on March 15, 2010)
- the anticipated progress of our research, development and clinical programs, including whether current and future clinical trials will achieve similar results to clinical trials... (Filed With SEC on March 15, 2010)
- the anticipated progress of our research, development and clinical programs, including whether current and future clinical trials will achieve similar results to clinical trials... (Filed With SEC on March 15, 2010)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- Ex-10.43 Exclusive License and Collaboration Agreement (Filed With SEC on March 11, 2008)
- Ex-10.37 Collaboration and License Agreement (Filed With SEC on November 3, 2006)
- Ex-10.24 Joint Collaboration & License Agreement (Filed With SEC on May 7, 2004)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
